Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers
Brandon M. Huffman(Harvard University), Samuel J. Klempner(Broad Institute), Adham Jurdi(University of the Incarnate Word), Farshid Dayyani(University of California, Irvine), Vasily N. Aushev(Natera (United States)), Meenakshi Malhotra(Natera (United States)), Giby V. George(Natera (United States)), Gregory P. Botta(Moores Cancer Center), Steven B. Maron(Memorial Sloan Kettering Cancer Center), Alexey Aleshin(Natera (United States)), Griffin Budde(Natera (United States)), Shifra Krinshpun(Natera (United States)), Pashtoon Murtaza Kasi(Cornell University), Daniel V.T. Catenacci(University of Chicago), Shruti Sharma(Natera (United States)), Joseph Chao(Amgen (United States)), Diana L. Hanna(University of Southern California), Solomon Moshkevich(Natera (United States))
Cited by 72
Related Papers
Colorectal cancer
|The Lancet|2019|5k
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.3k
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
|JAMA Oncology|2019|992
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
|Nature|2021|603